CGEN Q4 2024 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$202M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-95.6% YoY

Gross Profit

$796,00054.1% margin

Operating Income

-$7M-508.7% margin

Net Income

-$6M-415.8% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

-91.4%

Balance Sheet

Total Assets

$115M

Total Liabilities

$60M

Stockholders' Equity

$55M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$33M	-95.6%
Gross Profit	$796,000	$31M	-97.5%
Operating Income	-$7M	$18M	-141.6%
Net Income	-$6M	$10M	-163.0%